Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?

Home | About RECERCAT | Contact

Català | Castellano

All of RECERCAT

By Communities &
Collections By Defense Date By Authors By Titles By Subject

This Collection

By Defense Date By Authors By Titles By Subject

Statistics

View Statistics All RECERCAT

My RECERCAT

Other repositories directory

RECERCAT Home > Universitat de Barcelona > Medicina > Articles publicats en revistes (Medicina) > View document

To access the full text documents, please follow this link: http://hdl.handle.net/2445/18650

Title:	Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?
Author:	Burroughs, Andrew K.; Groszmann, Roberto J.; Bosch i Genover, Jaume; Grace, N.; Garcia-Tsao, G.; Patch, D.; García Pagán, Juan Carlos; Dagher, L.
Other authors:	Universitat de Barcelona
Abstract:	Chronic hepatitis C is a major healthcare problem. The response to antiviral therapy for patients with chronic hepatitis C has previously been defined biochemically and by PCR. However, changes in the hepatic venous pressure gradient (HVPG) may be considered as an adjunctive end point for the therapeutic evaluation of antiviral therapy in chronic hepatitis C. It is a validated technique which is safe, well tolerated, well established, and reproducible. Serial HVPG measurements may be the best way to evaluate response to therapy in chronic hepatitis C.
Subject(s):	-Hepatitis C -Virosi -Pressió venosa -Hepatitis C -Virus diseases -Venous pressure
Rights:	(c) BMJ Publishing Group Ltd and British Society of Gastroenterology, 2002
Document type:	Article Article - Published version
Published by:	BMJ Group
Share:

Show full item record

Related documents

Other documents of the same author

Incidence, prevalence and clinical significance of abnormal hematological indices in compensated cirrhosis

Qamar, A. A.; Grace, N. D.; Groszmann, R. J.; Garcia Tsao, Guadalupe; Bosch i Genover, Jaume; Burroughs, Andrew K.; Ripoll, C.; Maurer, R.; Planas, R.; Escorsell, A.; García Pagán, Juan Carlos; Patch, D.; Matloff, D. S.; Makuch, R.; Rendon, G.

Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club.

Wong, Florence; Bernardi, M. (Mauro); Balk, R.; Christman, B.; Moreau, R.; Garcia-Tsao, G.; Patch, D.; Soriano Pastor, Germán; Hoefs, J.; Navasa, Miquel

Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-Analysis

Turco, Laura; Villanueva, Candid; Mura, Vincenzo La; García Pagán, Juan Carlos; Reiberger, Thomas; Genescà, Joan; Groszmann, Roberto J.; Sharma, Barjesh C.; Merkel, Carlo; Bureau, Christophe; Alvarado, Edilmar; González-Abraldes Iglesias, Juan; Albillos, Agustín; Bañares, Rafael; Peck-Radosavljevic, Markus; Augustin, Salvador; Sarin, Shiv K.; Bosch, Jaime; García-Tsao, Guadalupe

Liraglutide improves liver microvascular dysfunction in cirrhosis: Evidence from translational studies

Mesquita, Fernanda Cristina de; Guixé Muntet, Sergi; Fernández Iglesias, Anabel; Maeso Díaz, Raquel; Vila, Sergi; Hide Alférez, Diana; Ortega Ribera, Martí; Rosa López, José Luis; García Pagán, Juan Carlos; Bosch i Genover, Jaume; Oliveira, Jarbas Rodrigues de; Gracia-Sancho, Jorge

Effects of warm ischemia and reperfusion on the liver microcirculatory phenotype of rats: underlying mechanisms and pharmacological therapy

Hide Alférez, Diana; Ortega Ribera, Martí; García Pagán, Juan Carlos; Peralta Uroz, Carmen; Bosch i Genover, Jaume; Gracia-Sancho, Jorge

Accesibility | Legal note | Cookies Policy

Coordination

Supporters